The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

The Trump administration canceled the grants this week, citing concerns that novel mRNA vaccine technology remains “under-tested,” posing a risk to public health.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

where ligands conjugated on the surface of nanoparticles could drive tissue tropisms of mRNA therapeutics. Building a base When asked about the progress Liberate has made on this pathway ...

Democratic generational battle takes shape{beacon} THE WHITE HOUSE ON THURSDAY raged against two federal courts that blocked ...

4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Plc - Final Results and Notice of AGM PR Newswire LONDON, United Kingdom, May 27 27 May 20244basebio plc("4basebio", the "Company" or the "Group")Final Results and ...